The Phase I clinical trial is an open label, multi-center dose escalation trial evaluating the safety and maximum tolerated dose of single dose administration of allogeneic MultiStem following
The trial is part of the Clinical Islet Transplantation (CIT) Consortium created by National Institutes of Health (NIH). The protocol, CIT-02, will focus on treating islets pre-transplant, and
Approximately 90 patients with endogenous anterior uveitis were studied in a multicenter, randomized, double-masked trial that compared the efficacy and safety of Durezol four times daily (QID) with
This initiative will enable Par to more effectively optimize its current product portfolio and its pipeline of first-to-file/first-to-market products. As a result, the company believes it will be
Parietex ProGrip mesh is said to be the first bicomponent mesh composed of monofilament polyester and a resorbable polylactic acid gripping system that facilitates a tension-free repair. The
According to the company, Conquest offers: 80 degrees of screw angulation; double helical bone screw thread design; toggle-free implant-instrument interface; facet friendly and low profile footprint; color-coded instruments
The newly enhanced Biodesign base material is said to offer surgeons better handling characteristics, long-term strength and faster tissue remodeling, thereby delivering better surgical outcomes and an improved
Scient’x is relocating its US headquarters to West Chester, Pennsylvania from Maitland, Florida effective end of October 2008. The new, larger facility will house both the commercial and
Alcon has entered into a licensing agreement with GlaxoSmithKline (GSK) for global ophthalmic rights to cilomilast, a phosphodiesterase IV inhibitor. In addition to this new agreement, Alcon expanded
Mr Stevens has over 30 years experience in the medical device market, and has held top management positions with several spine companies over the last 15 years. Wolfgang
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.